CPT code 82530 denotes a quantitative laboratory measurement of free (unbound) cortisol in a patient specimen, used to evaluate adrenal gland function and disorders of cortisol production. Nationally, this test supports diagnosis and management of endocrine conditions such as Cushing syndrome, adrenal insufficiency, and other disorders that alter cortisol dynamics. Its role in clinical pathways and utilization in outpatient and inpatient settings makes reimbursement and coding clarity important for laboratories and clinicians.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of clinical context and expected sites of service, plus an outline of what stakeholders typically review when assessing coverage and billing for this code: utilization benchmarks, payer coverage patterns, technical versus professional components, and common coding modifiers used in related lab services. This publication summarizes the code’s clinical purpose, typical laboratory workflow implications, and what to expect in payer interactions. Data not available in the input will be noted where applicable.